Is a complete AIM/SBTX research report available?

No complete published report is available for aim/SBTX (AIM/SBTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/SBTX (AIM/SBTX)

London Stock Exchange AIM: AIM/SBTX · GBX

GBX 9.10

-0.15 (-1.6%)· Recorded snapshot

Market cap	24M
Revenue (ttm)	5.2M
Net income (ttm)	-456.4K
EPS (ttm)	-GBX 0.00
Shares out	259.2M
Volume	24,566
Beta	0.10

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.2M
Net income (ttm): -456.4K
EPS (ttm): -GBX 0.00
Market cap: 24M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All AIM/SBTX indicators

Market & fundamental data

Available fields

182

Groups with data

Currency

GBP

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	41
Employees Change	26%
Employees Change Percent	173.3
Enterprise value	GBX 21.8M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BF33H870
Last refreshed	2026-09-13
Market cap	GBX 24M
Price	GBX 9.1
Price currency	GBX
Rev Per Employee	127,501.56x
Sector	Healthcare
Sector PE	20.55
Sector PE Fwd	13.32
Sic	2844
Symbol	aim/SBTX
Website	https://www.skinbiotherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1.9%
EV/Sales	4.17x
FCF yield	-8.22%
P/B ratio	3x
P/S ratio	4.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-20.95%
EBITDA Margin	-14.05%
Gross margin	60.95%
Gross Profit	GBX 3.2M
Gross Profit Growth	113.51%
Gross Profit Growth Q	37.27%
Gross Profit Growth3 Y	236.42%
Net Income	GBX -456,412
Net Income Growth Quarters	4%
Net Income Growth Years	1%
Pretax Margin	-8.95%
Profit Margin	-8.73%
Profit Per Employee	GBX -11,132
ROA	-8.1
Roa5y	-36.98
ROCE	-12.42
ROE	-7.32
Roe5y	-72.78
ROIC	-9.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-41.31%
Cagr3y	-24.32%
Cagr5y	-31.76%
EPS Growth Quarters	6
EPS Growth Years	3
Revenue Growth	95.16x
Revenue Growth Q	37.39x
Revenue Growth Qo Q	-29.25x
Revenue Growth Quarters	7x
Revenue Growth Years	3x
Revenue Growth3 Y	242.78x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.62
Assets	GBX 9.6M
Cash	GBX 3.1M
Current Assets	GBX 4.8M
Current Liabilities	GBX 783,327
Debt	GBX 939,165
Debt Equity	GBX 0.12
Debt FCF	GBX -0.48
Equity	GBX 8M
Interest Coverage	-8.93
Liabilities	GBX 1.6M
Long Term Assets	GBX 4.8M
Long Term Liabilities	GBX 842,670
Net Cash	GBX 2.2M
Net Cash By Market Cap	GBX 9.12
Net Cash Growth	938.28%
Net Debt Equity	GBX -0.27
Tangible Book Value	GBX 3.9M
Tangible Book Value Per Share	GBX 0.01
WACC	5.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.14
Inventory Turnover	2.33
Net Working Capital	GBX 996,277
Quick ratio	4.96
Working Capital	GBX 4M
Working Capital Turnover	GBX 2.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.39%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-41.29%
200-day SMA	13.08
3Y total return	-56.67%
50-day SMA	10.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.2%
All Time High	88
All Time High Change	-89.66%
All Time High Date	2021-05-26
All Time Low	5
All Time Low Change	82%
All Time Low Date	2020-03-27
ATR	0.73
Beta	0.1
Beta1y	-1.92
Beta2y	-0.83
Ch YTD	-42.22
High	9.1
High52	23
High52 Date	2026-01-12
High52ch	-60.43%
Low	9
Low52	5
Low52 Date	2026-03-23
Low52ch	82%
Ma50ch	-12.2%
Price vs 200-day SMA	-30.43%
RSI	24.55
RSI Monthly	41.72
RSI Weekly	43.19
Sharpe ratio	0.09x
Sharpe Ratio3y	0.32x
Sharpe Ratio5y	-0.09x
Sortino ratio	0.16
Sortino Ratio3y	0.52
Sortino Ratio5y	-0.06
Total Return	-17.39%
Tr YTD	-42.22
Tr1m	-17.27%
Tr1w	-4.21%
Tr3m	30%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	121,831,555%
Net Borrowing	-154,040
Shares Insiders	48.24%
Shares Institutions	48.32%
Shares Out	259,168,671
Shares Qo Q	11.2%
Shares Yo Y	17.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	132,173.35x
Bv Per Share	0.03
CAPEX	GBX -27,879
Ch1m	-17.27
Ch1w	-4.21
Ch1y	-41.29
Ch3m	30
Ch3y	-56.67
Ch5y	-85.2
Ch6m	-24.17
Change	-1.62%
Change From Open	1.11
Close	9.25
Days Gap	-2.7
Depreciation Amortization	360,916
Dollar Volume	223,550.6
Earnings Date	2026-12-03
EBIT	GBX -1.1M
EBITDA	GBX -734,472
EPS	GBX -0
F Score	4
FCF	GBX -2M
FCF EV Yield	-9.04x
FCF Per Share	GBX -0.01
Financing CF	4,006,706
Fiscal Year End	June
Founded	2,015
Goodwill	2,419,640
Income Tax	GBX -11,662
Investing CF	-177,133
Is Primary Listing	1
Last Earnings Date	2026-01-07
Last Report Date	2025-12-31
Ma150	12.23
Ma150ch	-25.57%
Ma20	9.5
Ma20ch	-4.21%
Net CF	1,887,712
Next Earnings Date	2026-12-03
Open	9
Position In Range	100
Ppne	671,160
Price Date	2026-09-11
Ptbv Ratio	6.22
Relative Volume	0.19x
Revenue	5,227,564x
Tax By Revenue	-0.22x
Tr6m	-24.17%
Volume	24,566
Z Score	14.24

AIM/SBTX (AIM/SBTX)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/SBTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/SBTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/SBTX

Frequently asked questions